Physio-Probe-High Permeability Cath
Research Industries
FDA Clearance Information
The physio-probe-high permeability cath was cleared by the FDA via the 510k pathway on December 29, 1983. It is manufactured by Research Industries and classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Percutaneous catheter use for vascular access and catheter-based procedures, consistent with the FDA product classification for percutaneous catheters.
- Use in procedures involving access to venous structures when the catheter is compatible with the planned intervention and labeled configuration.
Clinical Applications
- Catheter-based access to venous structures during interventional procedures.
- Assistance with venous stent placement for venous obstruction when consistent with the device's cleared labeling.
- Use in interventional radiology or vascular surgery procedures requiring percutaneous venous catheter access.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available FDA record does not specify catheter diameter, working length, tip configuration, guidewire compatibility, or maximum injection pressure; these details should be confirmed in the current product labeling.
- Use requires appropriate imaging guidance, sterile technique, and selection of an access route and catheter size suited to the target vessel and planned procedure.
- MRI safety is not established in the supplied record. Confirm MR Safe, MR Conditional, or MR Unsafe status with the device labeling or manufacturer before MRI.
- Potential contraindications and complications depend on the specific model and procedure and may include bleeding, infection, vessel injury, thrombosis, embolization, and contrast-related complications.
- The FDA clearance date does not confirm that the device remains commercially available or that the original labeling is current.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for physio-probe-high permeability cath?
The device is indicated for use in venous stenting procedures, particularly for treating venous obstructions.
What outcomes have been reported in clinical studies?
Studies report enhanced antibacterial efficiency when combining antimicrobial peptides with traditional antibiotics.
What complications have been reported?
Safety concerns include potential cytotoxicity and enzymatic susceptibility in related antimicrobial applications.